Research.

Chromosomal abnormalities in primary and secondary recurrent miscarriages: significance for PGT-A.

Cohen J, Kirshenbaum M, Grossman-Jonish A, Pras E, Carp H

J Assist Reprod Genet

Contemporary management of uterine fibroids.

Kirshenbaum M, Rozen G, Polyakov A

Aust J Gen Pract

Outcomes of oocyte cryopreservation: an analysis based on age and treatment indications.

Kirshenbaum M, et al.

Hum Reprod

Predicting IVF outcome in poor ovarian responders.

Lebovitz O, Haas J, Mor N, Zilberberg E, Aizer A, Kirshenbaum M, Orvieto R, Nahum R

BMC Womens Health

Amniotic fluid index measurements and correlation with fetal biometric parameters.

Kirshenbaum M, Ziv-Baran T, Katorza E

J Matern Fetal Neonatal Med

Recombinant FSH plus recombinant LH versus HMG: effect on ovarian stimulation outcomes.

Kirshenbaum M, Gil O, Haas J, Nahum R, Zilberberg E, Lebovitz O, Orvieto R

Reprod Biol Endocrinol

Cleavage vs blastocyst stage embryos: how are they interrelating?.

Zilberberg E, Casper R, Meriano J, Barzilay E, Aizer A, Kirshenbaum M, Orvieto R, Haas J

Arch Gynecol Obstet

A novel stimulation protocol for poor-responder patients.

Orvieto R, Nahum R, Aizer A, Haas J, Kirshenbaum M

Gynecol Obstet Invest

Endothelial function in placenta-mediated fetal growth restriction.

Kirshenbaum M, Topaz L, Baum M, Mazaki-Tovi S, Yinon Y

Placenta

Is embryo cryopreservation causing macrosomia—and what else?.

Orvieto R, Kirshenbaum M, Gleicher N

Front Endocrinol

Do follicles of obese patients yield competent oocytes/embryos?.

Orvieto R, Mohr-Sasson A, Aizer A, Nahum R, Blumenfeld S, Kirshenbaum M, Haas J

Gynecol Obstet Invest

Effect of ovarian stimulation on endothelial function.

Kirshenbaum M, Haas J, Nahum R, Aizer A, Yinon Y, Orvieto R

J Clin Endocrinol Metab

Obstetric and perinatal outcomes after PGT for monogenic diseases.

Feldman B, Orvieto R, Weisel M, Aizer A, Meyer R, Haas J, Kirshenbaum M

Obstet Gynecol

FMR1 premutation and fertility phenotype.

Friedman-Gohas M, Kirshenbaum M, Michaeli A, Domniz N, Elizur S, Raanani H, Orvieto R, Cohen Y

J Assist Reprod Genet

Stop GnRH-agonist combined with GnRH-antagonist protocol.

Orvieto R, Kirshenbaum M, Galiano V, Zilberberg E, Haas J, Nahum R

Gynecol Obstet Invest

Controlled ovarian hyperstimulation protocol for poor responders.

Orvieto R, Kirshenbaum M, Galiano V, Elkan-Miller T, Zilberberg E, Haas J, Nahum R

Front Endocrinol

Should we offer IVF to couples with unexplained recurrent pregnancy loss?.

Kirshenbaum M, Orvieto R

J Clin Med

Premature ovarian insufficiency and autoimmunity: an update appraisal.

Kirshenbaum M, Orvieto R

J Assist Reprod Genet

Embryo sex ratios in PGD cycles.

Kirshenbaum M, Feldman B, Aizer A, Haas J, Orvieto R

Gynecol Endocrinol

Influence of seasonal variation on IVF success.

Kirshenbaum M, Ben-David A, Zilberberg E, Elkan-Miller T, Haas J, Orvieto R

PLoS One

Pregnancy outcomes in Takayasu’s arteritis.

Kirshenbaum M, Simchen MJ

J Matern Fetal Neonatal Med

Antenatal steroids prior to elective caesarean section and neonatal outcomes.

Kirshenbaum M, Mazaki-Tovi S, Amikam U, Mazkereth R, Sivan E, Schiff E, Yinon Y

Arch Gynecol Obstet

Mode of delivery in second stage failure.

Hendler I, Kirshenbaum M, Barg M, Kees S, Mazaki-Tovi S, Moran O, Kalter A, Schiff E

J Matern Fetal Neonatal Med

Authors’ response regarding mode of delivery in second stage failure.

Hendler I, Kirshenbaum M

J Matern Fetal Neonatal Med